Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 23, 16:00
541.00
2.1 (0.39%)
VOLUME 45,394
LIVE
NSE
Jun 23, 15:49
541.15
1 (0.19%)
VOLUME 603,986
News on Cipla
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cipla settles patent infringement case with Roche over cancer drug Tarceva

3.37 pm | 22 Jun 2017 |  Source: Moneycontrol.com

“As part of the agreement, the companies have ceased all relevant patent litigation on this product and Cipla has acknowledged the validity of the p...

Sell Cipla, Biocon; buy VRL Logistics: Ashwani Gujral 

11.49 am | 19 Jun 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com advises selling Cipla and Biocon....

Cancer drug: SC allows Cipla to withdraw appeal against Roche

2.41 pm | 16 Jun 2017 |  Source: PTI

The apex court was informed that the two companies on May 30 had arrived at a settlement before the Delhi High Court to close the patent dispute betwe...

Warning! India may face heavy shortage of medicines from mid-June due to GST-caused disruption

9.04 pm | 05 Jun 2017 |  Source: Moneycontrol.com

Sales of drugs will be two-three times higher from June onward due to onset of monsoon bringing in seasonal diseases....

Hold Cipla; target of Rs 470: ICICI Direct

4.19 pm | 29 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 470 in its research report dated May 26, 2017....

Hold Cipla; target of Rs 510: Edelweiss

4.47 pm | 26 May 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Cipla with a target price of Rs 510 in its research report dated May 25, 2017....

CLSA downgrades Cipla to underperform post Q4; cuts target price to Rs 525

9.14 am | 26 May 2017 |  Source: Moneycontrol.com

Cipla Q4 net loss narrowed to Rs61.79 crore but muted EBITDA margins led to a downgrade by CLSA to underperform from outperform earlier....

Cipla puts biosimilar business on backburner as part of business rationalisation

7.49 am | 26 May 2017 |  Source: Moneycontrol.com

Umang Vohra, MD and Global CEO of Cipla, said the company has always exited businesses where it is not best suited to play the game....

Cipla’s post Q4 net loss of Rs 61.8 cr; depreciation & impairment weigh in on financials 

4.58 pm | 25 May 2017 |  Source: Moneycontrol.com

The consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) came in at Rs 506.2 crore against Rs 176.1 crore during March...

Hold Cipla, may test Rs 600: Rajesh Agarwal

3.38 pm | 25 May 2017 |  Source: CNBC-TV18

Rajesh Agarwal of AUM Capital is of the view that one may hold Cipla....

Buy Cipla at around Rs 400, says Rajat Bose 

3.33 pm | 25 May 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com advises buying Cipla at around Rs 400....

Cipla Q4: Net profit seen at Rs 346.8 crore, revenues could rise to Rs 3,790 crore: Poll 

5.53 pm | 24 May 2017 |  Source: Moneycontrol.com

Meanwhile, the earnings before interest, taxes, depreciation and amortisation could come in at Rs 675.4 crore, while its operating margin is seen at 1...

Cipla's Press Conferece Call to be held on May 29, 2017

6.33 pm | 19 May 2017 |  Source: Moneycontrol.com

We are enclosing herewith schedule of Press Conference and Earnings Conference call to be held on May 29, 2017....

Sell Cipla, buy Mangalore Refineries & Petrochemicals: Mitessh Thakkar 

10.35 am | 18 May 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com is of the view that one can sell Cipla and buy Mangalore Refineries & Petrochemicals....

Cipla to consider FY17 results on May 25, 2017

1.09 pm | 15 May 2017 |  Source: Moneycontrol.com

Cipla Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 25, 2017, inter alia, to consider an...

Resistance for bank Nifty at 22850; Tech Mahindra, Cipla bullish plays: Prakash Gaba 

8.00 am | 15 May 2017 |  Source: Moneycontrol.com

According to Prakash Gaba of prakashgaba.com, Nifty has support at 9340 and resistance at 9500 while Bank Nifty has support at 22500 and resistance at...

Cipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

1.17 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.6 percent Q-o-Q (up 17.9 percent Y-o-Y) to Rs 3852.5 crore, according to ICICI Securities. Cipla to report net...

Buy Cipla; target of Rs 740: Centrum

3.30 pm | 15 Feb 2017 |  Source: Moneycontrol.com

Centrum is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 740 in its research report dated February 08, 2017....

Hold Cipla; target of Rs 575: ICICI Direct

2.13 pm | 13 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 575 in its research report dated February 09, 2017....

Buy Cipla; target of Rs 690: KR Choksey

10.46 am | 13 Feb 2017 |  Source: Moneycontrol.com

KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 690 in its research report dated February 09, 2017....

1 2 3 4
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.